P/E Ratio
Search documents
P/E Ratio Insights for Aramark - Aramark (NYSE:ARMK)
Benzinga· 2025-12-03 16:00
Core Viewpoint - Aramark Inc. (NYSE:ARMK) is currently priced at $37.15, reflecting a slight increase of 0.27% in the current market session, but has seen a decrease of 1.23% over the past month and 10.54% over the past year, raising questions about its valuation despite current performance [1]. Group 1: P/E Ratio Analysis - The P/E ratio is a critical metric for investors, comparing the current share price to the company's earnings per share (EPS), and is used to assess performance against historical data and industry benchmarks [5]. - Aramark's P/E ratio is lower than the industry average P/E of 50.1 for the Hotels, Restaurants & Leisure sector, suggesting that the stock may be undervalued despite potential concerns about its performance relative to peers [6]. - A low P/E ratio can indicate undervaluation but may also reflect weak growth prospects or financial instability, emphasizing the need for a comprehensive analysis beyond just this metric [9][10].
P/E Ratio Insights for Adobe - Adobe (NASDAQ:ADBE)
Benzinga· 2025-12-02 19:00
In the current market session, Adobe Inc. (NASDAQ:ADBE) price is at $324.55, after a 0.53% increase. However, over the past month, the stock decreased by 3.22%, and in the past year, by 39.51%. Shareholders might be interested in knowing whether the stock is undervalued, even if the company is performing up to par in the current session. A Look at Adobe P/E Relative to Its CompetitorsThe P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, his ...
P/E Ratio Insights for Grand Canyon Education - Grand Canyon Education (NASDAQ:LOPE)
Benzinga· 2025-12-01 15:00
In the current market session, Grand Canyon Education Inc. (NASDAQ:LOPE) price is at $158.00, after a 0.16% spike. However, over the past month, the stock decreased by 15.84%, and in the past year, by 6.49%. Shareholders might be interested in knowing whether the stock is undervalued, even if the company is performing up to par in the current session. How Does Grand Canyon Education P/E Compare to Other Companies?The P/E ratio measures the current share price to the company's EPS. It is used by long-term in ...
P/E Ratio Insights for Celestica - Celestica (NYSE:CLS)
Benzinga· 2025-11-28 16:00
Core Insights - Celestica Inc. (NYSE:CLS) has experienced a share price of $338.72, reflecting a 1.95% increase in the current market session, while the stock has decreased by 1.67% over the past month but has risen by 298.68% in the past year [1] Group 1: P/E Ratio Analysis - The P/E ratio is a critical metric for long-term shareholders to evaluate the company's market performance against historical earnings and industry benchmarks [5] - Celestica has a P/E ratio of 54.02, which is higher than the industry average P/E ratio of 38.73 for the Electronic Equipment, Instruments & Components sector, suggesting that Celestica may outperform its industry peers in the future, although it raises concerns about potential overvaluation [6] - While a lower P/E ratio can indicate undervaluation, it may also reflect a lack of expected future growth, highlighting the need for a comprehensive analysis that includes other financial metrics and qualitative factors [9][10]
P/E Ratio Insights for Southern Missouri Bancorp - Southern Missouri Bancorp (NASDAQ:SMBC)
Benzinga· 2025-11-27 19:00
Core Viewpoint - Southern Missouri Bancorp Inc. (NASDAQ:SMBC) shares are currently trading at $56.66, reflecting a slight increase of 0.05% in the current session, with a notable 7.01% rise over the past month, but a decline of 13.69% over the past year, raising questions about potential undervaluation despite the company's current performance [1]. Group 1: Stock Performance - The stock has experienced a 7.01% increase over the past month [1]. - Over the past year, the stock has decreased by 13.69% [1]. Group 2: P/E Ratio Analysis - Southern Missouri Bancorp has a lower P/E ratio compared to the aggregate P/E of 11.2 for the Banks industry, which may suggest that the stock is undervalued or that shareholders do not expect better future performance [5][6]. - A lower P/E ratio can indicate potential undervaluation, but it may also reflect weak growth prospects or financial instability [10]. Group 3: Investment Considerations - The P/E ratio is a valuable tool for assessing market performance, but it should be used cautiously and in conjunction with other financial metrics and qualitative factors to make informed investment decisions [9][10].
P/E Ratio Insights for IDEXX Laboratories - IDEXX Laboratories (NASDAQ:IDXX)
Benzinga· 2025-11-25 22:00
Core Viewpoint - IDEXX Laboratories Inc. has shown significant stock performance, with a 20.86% increase over the past month and an 81.78% increase over the past year, leading to discussions about its valuation based on the price-to-earnings (P/E) ratio [1][3]. Group 1: Stock Performance - The current stock price of IDEXX Laboratories Inc. is $766.68, reflecting a 1.93% increase in the current session [1]. - Long-term shareholders are optimistic about the company's performance due to substantial stock price increases [1]. Group 2: P/E Ratio Analysis - The P/E ratio is a critical metric for evaluating the company's market performance, comparing the current share price to its earnings per share (EPS) [3]. - IDEXX Laboratories Inc. has a P/E ratio of 59.65, which is higher than the industry average of 48.46 in the Health Care Equipment & Supplies sector, suggesting that investors may expect better performance from IDEXX compared to its peers [4]. - A higher P/E ratio may indicate that the stock is overvalued, but it could also reflect investor confidence in future growth and potential dividend increases [3][4]. Group 3: Limitations of P/E Ratio - While the P/E ratio is a useful tool for market performance analysis, it has limitations and should not be used in isolation [7][8]. - A lower P/E ratio might suggest undervaluation, but it could also indicate a lack of expected future growth [8]. - Other factors, such as industry trends and business cycles, should be considered alongside the P/E ratio for informed investment decisions [8].
X @Messari
Messari· 2025-11-24 20:33
Over the past 12 months, @THORChain has earned $35.7 million, reflecting strong fee capture from sustained activity despite market volatility.Based on its Q3 closing market capitalization of $400.4 million, THORChain has a trailing P/E ratio of 11.21Full FREE report below 👇 https://t.co/ZS1229fx0E ...
P/E Ratio Insights for Cheniere Energy - Cheniere Energy (NYSE:LNG)
Benzinga· 2025-11-24 16:00
Core Viewpoint - Cheniere Energy Inc. is currently experiencing a decline in stock price, prompting long-term shareholders to evaluate the company's price-to-earnings (P/E) ratio as a potential indicator of future performance [1][5]. Group 1: Stock Performance - Cheniere Energy's stock is trading at $203.71, reflecting a decrease of 0.87% in the current session [1]. - Over the past month, the stock has decreased by 6.51%, and over the past year, it has declined by 9.00% [1]. Group 2: P/E Ratio Analysis - The P/E ratio is a critical metric for assessing a company's market performance, comparing the current share price to the company's earnings per share (EPS) [5]. - Cheniere Energy has a lower P/E ratio compared to the aggregate P/E of 20.35 for the Oil, Gas & Consumable Fuels industry, suggesting it may be undervalued [6]. - A lower P/E ratio can indicate that shareholders do not expect future growth, but it may also suggest undervaluation [9][10]. Group 3: Investment Considerations - Investors should not rely solely on the P/E ratio for investment decisions, as it should be considered alongside other financial metrics and qualitative factors [10].
P/E Ratio Insights for Assurant - Assurant (NYSE:AIZ)
Benzinga· 2025-11-20 18:00
Core Viewpoint - Assurant Inc. shares are currently trading at $225.25, reflecting a 0.28% increase, with a 6.46% rise over the past month, but a 0.40% decline over the past year, raising questions about potential undervaluation despite current performance [1]. Group 1: P/E Ratio Analysis - The P/E ratio is a critical metric for investors, comparing the current share price to the company's earnings per share (EPS), indicating market expectations for future performance [5]. - Assurant Inc. has a P/E ratio of 13.69, which is lower than the insurance industry's average P/E ratio of 13.99, suggesting that the stock may be undervalued or could perform worse than its peers [6]. - A low P/E ratio can indicate undervaluation but may also reflect weak growth prospects or financial instability, emphasizing the need for a comprehensive analysis of financial health [9].
P/E Ratio Insights for TransUnion - TransUnion (NYSE:TRU)
Benzinga· 2025-11-19 22:00
Core Viewpoint - TransUnion Inc. shares are currently trading at $81.88, reflecting a 2.13% increase, but have decreased by 16.95% over the past year, raising questions about potential undervaluation despite current performance [1]. Group 1: Stock Performance - The stock has increased by 1.50% over the past month, indicating some short-term positive momentum [1]. - Over the past year, the stock has experienced a significant decline of 16.95%, suggesting potential long-term challenges [1]. Group 2: P/E Ratio Analysis - TransUnion has a P/E ratio of 37.46, which is higher than the Professional Services industry average of 35.84, indicating that investors may expect better future performance from TransUnion compared to its peers [6]. - A higher P/E ratio may suggest that the stock is overvalued, although it could also reflect investor optimism regarding future performance and potential dividend increases [5][6]. Group 3: Investment Considerations - The P/E ratio is a useful metric for evaluating market performance, but it should be interpreted cautiously as a low P/E could indicate undervaluation or weak growth prospects [9][10]. - Investors should consider the P/E ratio alongside other financial metrics, industry trends, and qualitative factors for a comprehensive analysis of the company's financial health [10].